The increased abundance of IGHA1 IGHA2 in the serum from neonates with NEC may be reflective of the gut barrier dysfunction observed during NEC (45), which would result in increased circulating levels of this primarily intestinal antibody. This evidence concerns the gene IGHA2 and necrotizing enterocolitis.